| pubmed-article:17354226 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:17354226 | lifeskim:mentions | umls-concept:C0033325 | lld:lifeskim |
| pubmed-article:17354226 | lifeskim:mentions | umls-concept:C0376358 | lld:lifeskim |
| pubmed-article:17354226 | lifeskim:mentions | umls-concept:C0162698 | lld:lifeskim |
| pubmed-article:17354226 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:17354226 | lifeskim:mentions | umls-concept:C0031809 | lld:lifeskim |
| pubmed-article:17354226 | lifeskim:mentions | umls-concept:C0008300 | lld:lifeskim |
| pubmed-article:17354226 | lifeskim:mentions | umls-concept:C0439810 | lld:lifeskim |
| pubmed-article:17354226 | lifeskim:mentions | umls-concept:C0918012 | lld:lifeskim |
| pubmed-article:17354226 | lifeskim:mentions | umls-concept:C0871685 | lld:lifeskim |
| pubmed-article:17354226 | pubmed:issue | 9 | lld:pubmed |
| pubmed-article:17354226 | pubmed:dateCreated | 2007-5-24 | lld:pubmed |
| pubmed-article:17354226 | pubmed:abstractText | Among the most pressing challenges that face physicians who care for men with prostate cancer is evaluating the patient's potential for benefiting from treatment. Because prostate cancer often follows an indolent course, the presence and severity of comorbidities may influence the decision to treat the patient aggressively. The authors adapted the Total Illness Burden Index (TIBI) for use in decision-making among men with prostate cancer at the time of the visit. | lld:pubmed |
| pubmed-article:17354226 | pubmed:language | eng | lld:pubmed |
| pubmed-article:17354226 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17354226 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:17354226 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:17354226 | pubmed:month | May | lld:pubmed |
| pubmed-article:17354226 | pubmed:issn | 0008-543X | lld:pubmed |
| pubmed-article:17354226 | pubmed:author | pubmed-author:LitwinMark... | lld:pubmed |
| pubmed-article:17354226 | pubmed:author | pubmed-author:GreenfieldShe... | lld:pubmed |
| pubmed-article:17354226 | pubmed:author | pubmed-author:KaplanSherrie... | lld:pubmed |
| pubmed-article:17354226 | pubmed:author | pubmed-author:LubeckDeborah... | lld:pubmed |
| pubmed-article:17354226 | pubmed:author | pubmed-author:ElkinEric PEP | lld:pubmed |
| pubmed-article:17354226 | pubmed:author | pubmed-author:BroeringJeane... | lld:pubmed |
| pubmed-article:17354226 | pubmed:copyrightInfo | Copyright (c) 2007 American Cancer Society | lld:pubmed |
| pubmed-article:17354226 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:17354226 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:17354226 | pubmed:volume | 109 | lld:pubmed |
| pubmed-article:17354226 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:17354226 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:17354226 | pubmed:pagination | 1777-83 | lld:pubmed |
| pubmed-article:17354226 | pubmed:dateRevised | 2010-11-18 | lld:pubmed |
| pubmed-article:17354226 | pubmed:meshHeading | pubmed-meshheading:17354226... | lld:pubmed |
| pubmed-article:17354226 | pubmed:meshHeading | pubmed-meshheading:17354226... | lld:pubmed |
| pubmed-article:17354226 | pubmed:meshHeading | pubmed-meshheading:17354226... | lld:pubmed |
| pubmed-article:17354226 | pubmed:meshHeading | pubmed-meshheading:17354226... | lld:pubmed |
| pubmed-article:17354226 | pubmed:meshHeading | pubmed-meshheading:17354226... | lld:pubmed |
| pubmed-article:17354226 | pubmed:meshHeading | pubmed-meshheading:17354226... | lld:pubmed |
| pubmed-article:17354226 | pubmed:meshHeading | pubmed-meshheading:17354226... | lld:pubmed |
| pubmed-article:17354226 | pubmed:meshHeading | pubmed-meshheading:17354226... | lld:pubmed |
| pubmed-article:17354226 | pubmed:meshHeading | pubmed-meshheading:17354226... | lld:pubmed |
| pubmed-article:17354226 | pubmed:year | 2007 | lld:pubmed |
| pubmed-article:17354226 | pubmed:articleTitle | Assessment of prognosis with the total illness burden index for prostate cancer: aiding clinicians in treatment choice. | lld:pubmed |
| pubmed-article:17354226 | pubmed:affiliation | Department of Urology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California, USA. | lld:pubmed |
| pubmed-article:17354226 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17354226 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17354226 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17354226 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17354226 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17354226 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17354226 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17354226 | lld:pubmed |
